| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/15/2004 | US20040071679 Topical application of Lactobacillus strain; colorimetric analysis |
| 04/15/2004 | US20040071675 Retrograde transport delivering entity of interest to tyrosine hydroxylase positive neuron; Parkinson's disease; rabies g protein transduction |
| 04/15/2004 | US20040071674 Directly implanting; permanent engrafting; stably expressing variety of gene products; differentiating into specialized cells; nitric oxide synthase |
| 04/15/2004 | US20040071671 Cell therapy method for the treatment of tumors |
| 04/15/2004 | US20040071670 Transplantation cell kits for re-myelination of nerve cells |
| 04/15/2004 | US20040071669 Transplants for myocardial scars |
| 04/15/2004 | US20040071667 Use of cytokines and mitogens to inhibit pathological immune responses |
| 04/15/2004 | US20040071665 Introducing inoculum to heart consisting of at least two of stem, progenitor, lineage committed and differentiated cells to develop in situ as integrated cells |
| 04/15/2004 | US20040071663 Pesticidal and antiparasitic compositions |
| 04/15/2004 | US20040071662 Dendritic cells; methods |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071637 Method for repairing a damaged portion of a human organ |
| 04/15/2004 | DE29624488U1 Inactivating parvovirus in blood and blood prods. with type C UV light - and device for the process, is simple and rapid and retains functionality of proteins |
| 04/15/2004 | DE10337340A1 Zusammensetzung Composition |
| 04/15/2004 | CA2501291A1 Compositions comprising lactobacillus acidophilus and propionibacterium freudenreichii for use in reducing pathogen growth in ruminants |
| 04/15/2004 | CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | CA2500410A1 Programmable scaffold and methods for making and using the same |
| 04/15/2004 | CA2500408A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 04/14/2004 | EP1407788A2 Myoblast therapy for mammalian diseases |
| 04/14/2004 | EP1407779A1 Use of ghrelin for treating low body weight and body fat in gastrectomized individuals |
| 04/14/2004 | EP1407678A1 Capsules containing vital cells or tissues |
| 04/14/2004 | EP1407261A1 In vivo bioreactors |
| 04/14/2004 | EP1407033A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 04/14/2004 | EP1407032A1 Anti-neoplastic viral agents |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1407003A1 Liver cell progenitor and use for treatment of liver diseases |
| 04/14/2004 | EP1406998A2 Liver engrafting cells, assays, and uses thereof |
| 04/14/2004 | EP1406930A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 04/14/2004 | EP1406666A2 Adenoviral vectors with cell type specificity for mesenchymal cells |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406642A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 04/14/2004 | EP1406641A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/14/2004 | EP1406573A2 Conditioned cell culture media and uses thereof |
| 04/14/2004 | EP1406514A1 Enteral formulations |
| 04/14/2004 | EP1406513A1 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid |
| 04/14/2004 | EP0927040B1 Process to obtain oestrogens from mare's urine |
| 04/14/2004 | EP0923381B1 Method to obtain oestrogens from mare's urine |
| 04/14/2004 | EP0883406B1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489471A Educated NKT cells and their uses in the treatment of immune-related disorder |
| 04/14/2004 | CN1488757A Human vasular endothelial growth factor recombinant adenovirus and preparing method use thereof |
| 04/14/2004 | CN1488396A Chinese medicine for treating asynodia |
| 04/14/2004 | CN1488392A Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 04/14/2004 | CN1488366A Chinese medicine for treating hypotension and preparing method thereof |
| 04/14/2004 | CN1488363A Method for manufacturing medical health-care beauty article |
| 04/14/2004 | CN1488362A Chinese medicine preparation capable of promoting, milk secretion for delivery woman |
| 04/14/2004 | CN1488361A Low lectin general blood plasma |
| 04/14/2004 | CN1488357A Medicine for treating phthisis-zheyin capsule and process technique |
| 04/14/2004 | CN1488281A Method for separating functional factor in royal jelly |
| 04/14/2004 | CN1145495C Orally applied medicine for treating diseases caused by Yang deficciency and its producing method |
| 04/14/2004 | CN1145494C Medicine for treating nasosinusitis and its preparation method |
| 04/14/2004 | CN1145493C Materials for preventing arteriosclerosis |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6720136 Solid phase quenching systems |
| 04/13/2004 | US6720010 Composition having antihepatitic activity |
| 04/13/2004 | US6720009 Matrix protein compositions for treating infection |
| 04/13/2004 | US6719984 Administering low molecular weight, immunoglobulin-free fractions isolated from mammals; veterinary medicine; treating viral diseases |
| 04/13/2004 | US6719982 Transcriptional activation is prevented; nervous system disorders; gene therapy; genetic engineering and expression |
| 04/13/2004 | US6719970 Injecting live chondrocytes and bicompatible, biodegradable polymer microparticles comprising bioactive agent |
| 04/13/2004 | US6719805 Devices and methods for treating tissue |
| 04/13/2004 | US6718986 Mixed chimerism and tolerance |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2276747C Methods and devices for the reduction of small organic compounds from blood products |
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029231A1 Compositions and methods for amplification of human stem cells |
| 04/08/2004 | WO2004029230A2 Cells on a support matrix for tissue repair |
| 04/08/2004 | WO2004029198A2 Immune t-cell stimulation |
| 04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
| 04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | WO2004028441A2 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 04/08/2004 | WO2004028243A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | WO2004018654A3 Cell culture surface |
| 04/08/2004 | WO2004011631A3 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
| 04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/08/2004 | WO2004003182A3 Homozygous stem cells isolated from pathogenic oocytes |
| 04/08/2004 | WO2003101387A3 Globulin protein to lower cholesterol in humans |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100023A3 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 04/08/2004 | WO2003078597A3 Tissue engineering |
| 04/08/2004 | WO2003077852A3 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
| 04/08/2004 | WO2003072748A3 Bioengineered tissue substitutes |
| 04/08/2004 | WO2003070083A3 Endothelial precursor cells for enhancing and restoring vascular function |
| 04/08/2004 | WO2003066843A3 Method for the production of a nerve transplant |
| 04/08/2004 | WO2003057157A3 A stable aqueous suspension |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/08/2004 | WO2002086082A3 Isolation of neural stem cells using gangliosides and other surface markers |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | WO2002072762A9 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
| 04/08/2004 | US20040067889 Protease inhibitors; indicator of congestive heart failure |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067583 Methods for immortalizing cells |
| 04/08/2004 | US20040067582 Preparing metabolically non-viable and/or reproductively non-viable cells for use in tissue transplantation and grafting; prosthetics |
| 04/08/2004 | US20040067573 Lactobacillus culture for use in reducing gastrointestinal inflammation; antiinflammatory agents |
| 04/08/2004 | US20040067260 Stable aqueous suspension |